Related Experiment Video
Updated: Feb 22, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Palbociclib-induced autophagy and senescence in gastric cancer cells
Claudio A Valenzuela1, Leandro Vargas1, Valentina Martinez1
1Center for Medical Research, University of Talca School of Medicine, Avenida Lircay S/N, Talca, Chile.
Abstract:
Targeting cyclin D-CDK4/6 kinase complexes has recently been shown to increase the survival of breast cancer patients with estrogen receptor positive breast tumors. Based on these outcomes, CDK4/6 inhibitors are currently being tested, alone o in combination with other drugs, in the treatment of other malignancies characterized by hyper-activation of cyclin D-CDK4/6 complexes. Nonetheless, a better understanding of the cellular processes that are implemented in response to CDK4/6 inhibition is necessary to expand the therapeutic window and confront the development of drug resistance. Herein, we show that, similar to mammary cells, gastric cancer cells are sensitive to the CDK4/6 inhibitor Palbociclib. Inhibition of CDK4/6 in gastric cancer cells leads to the implementation of cellular senescence. However, whether or not this response is accompanied by induction of autophagy seems to depend on both the pRB and p53 status. In cells retaining expression of both tumor suppressive proteins (AGS gastric cancer cells), exposure to Palbociclib induces senescence and autophagy. However, the simultaneous blockade of CDK4/6 and autophagy in these cells exacerbates the senescence phenotype, an indication that autophagy in these experimental settings represents an adaptive mechanism that promotes cell survival rather than being an effector mechanism of senescence. Interestingly, knocking down p53 resulted in senescence reduction and autophagy blockade, the latter apparently involving a disruption of the degradation of autophagosome cargo.
Insights
CDK4/6 inhibitors like Palbociclib induce cellular senescence in gastric cancer cells. Autophagy acts as a survival mechanism, and its blockade exacerbates senescence, especially when p53 is present.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Targeting cyclin D-CDK4/6 kinase complexes improves survival in estrogen receptor-positive breast cancer.
- CDK4/6 inhibitors are being investigated for other cancers with hyperactive cyclin D-CDK4/6 pathways.
- Understanding cellular responses to CDK4/6 inhibition is crucial for expanding therapeutic use and overcoming resistance.
Purpose of the Study:
- To investigate the sensitivity of gastric cancer cells to the CDK4/6 inhibitor Palbociclib.
- To elucidate the cellular processes, including senescence and autophagy, induced by CDK4/6 inhibition in gastric cancer.
- To determine the role of pRB and p53 status in mediating these cellular responses.
Main Methods:
- Treatment of gastric cancer cells (AGS) with Palbociclib.
- Assessment of cellular senescence induction.
- Analysis of autophagy markers and autophagic flux.
- Manipulation of p53 expression via knockdown.
Main Results:
- Gastric cancer cells exhibit sensitivity to Palbociclib, leading to cellular senescence.
- In p53 and pRB-expressing cells, Palbociclib induces both senescence and autophagy.
- Simultaneous inhibition of CDK4/6 and autophagy worsens senescence, indicating autophagy's pro-survival role.
- p53 knockdown reduces senescence and blocks autophagy, disrupting cargo degradation.
Conclusions:
- CDK4/6 inhibition with Palbociclib is a potential therapeutic strategy for gastric cancer.
- Autophagy functions as an adaptive survival mechanism in response to CDK4/6 inhibition in gastric cancer.
- The p53 tumor suppressor protein plays a significant role in regulating both senescence and autophagy induction following CDK4/6 inhibition.
More Related Videos
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
09:51Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Related Concept Videos
Replicative Cell Senescence
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Intrinsic Apoptotic Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Inhibition of Cdk Activity
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...